Quest Diagnostics Incorporated Stock

Equities

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-05-31 pm EDT 5-day change 1st Jan Change
142 USD +1.89% Intraday chart for Quest Diagnostics Incorporated +0.49% +2.97%
Sales 2024 * 9.45B Sales 2025 * 9.76B Capitalization 15.77B
Net income 2024 * 894M Net income 2025 * 962M EV / Sales 2024 * 2.1 x
Net Debt 2024 * 4.02B Net Debt 2025 * 3.55B EV / Sales 2025 * 1.98 x
P/E ratio 2024 *
18.2 x
P/E ratio 2025 *
16.7 x
Employees 44,000
Yield 2024 *
2.08%
Yield 2025 *
2.11%
Free-Float 68.24%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.89%
1 week+0.49%
1 month+3.21%
3 months+13.87%
6 months+4.26%
Current year+2.97%
More quotes
1 week
137.34
Extreme 137.335
142.06
1 month
135.27
Extreme 135.265
145.62
Current year
123.04
Extreme 123.04
145.62
1 year
119.59
Extreme 119.59
145.62
3 years
119.59
Extreme 119.59
174.16
5 years
73.02
Extreme 73.02
174.16
10 years
56.27
Extreme 56.27
174.16
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 13-03-31
Director of Finance/CFO 54 22-07-10
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 70 19-02-17
Director/Board Member 66 11-12-06
Director/Board Member 74 04-11-30
More insiders
Date Price Change Volume
24-05-31 142 +1.89% 2,238,021
24-05-30 139.3 +0.82% 838,572
24-05-29 138.2 -0.52% 986,770
24-05-28 138.9 -1.68% 886,264
24-05-24 141.3 +0.89% 647,499

Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT

More quotes
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
142 USD
Average target price
147 USD
Spread / Average Target
+3.54%
Consensus